The role of IGFBP3 functional polymorphisms in the risk of gastric cancer in a high-risk Chinese population

European Journal of Cancer Prevention

Volumn 17, Issue 2, 2008, Pages 82-87

  Chen, Wensen ^a   Wang, Lina ^a   Ke, Qiao ^a   Jin, Guangfu ^a   Tan, Yongfei ^b   Zhou, Yan ^b   Hu, Zhibin ^a   Ma, Hongxia ^a   Wang, Jianmin ^c   Hua, Zhaolai ^c   Ding, Weiliang ^b   Shen, Jing ^a   Xu, Yaochu ^a   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

^c Yangzhong Cancer Institute   (China)

Author keywords

Functional polymorphism; Gastric cancer; IGFBP3; Molecular epidemiology

Indexed keywords

TUMOR MARKER;

ADULT; ALLELE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH CANCER; WILD TYPE;

AGED; ALLELES; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 39749183437     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32809b4cff     Document Type: Article

References (34)

1. Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, et al. (2006). IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15:1-10.
2. Buckway CK, Wilson EM, Ahlsen M, Bang P, Oh Y, Rosenfeld RG (2001). Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab 86:4943-4950.
3. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S, et al. (2006). Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94:299-307.
4. Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, et al. (2001). Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86:1274-1280.
5. Eggermann K, Wollmann HA, Tomiuk J, Ranke MB, Kaiser P, Eggermann T (1999). Screening for mutations in the promoter and the coding region of the IGFBP1 and IGFBP3 genes in Silver-Russell syndrome patients. Hum Hered 49:123-128.
6. Furstenberger G, Senn HJ (2002). Insulin-like growth factors and cancer. Lancet Oncol 3:298-302.
7. Gleeson LM, Chakraborty C, McKinnon T, Lala PK (2001). Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab 86:2484-2493.
8. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. (1996). Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98:2612-2615.
9. Imai Y, Moralez A, Andag U, Clarke JB, Busby WH Jr, Clemmons DR (2000). Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275:18188-18194.
10. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, et al. (2001). Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10:377-384.
11. Jones JI, Gockerman A, Busby WH Jr, Wright G, Clemmons DR. (1993). Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A 90:10553-10557.
12. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000). The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244.
13. Le Marchand L, Kolonel LN, Henderson BE, Wilkens LR (2005). Association of an exon 1 polymorphism in the IGFBP3 gene with circulating IGFBP-3 levels and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14:1319-1321.
14. Li L, Cicek MS, Casey G, Witte JS (2004). No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiol Biomarkers Prev 13:497-498.
15. London SJ, Yuan JM, Travlos GS, Gao YT, Wilson RE, Ross RK, Yu MC (2002). Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Ins 94:749-754.
16. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625.
17. Mohan S, Baylink DJ (2002). IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31.
18. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD (2005). Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors. Cancer Epidemiol Biomarkers Prev 14:1394-1401.
19. Perks CM, Newcomb PV, Norman MR, Holly JM (1999). Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol 22:141-150.
20. Pollak M (2000). Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36:1224-1228.
21. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353.
22. Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, et al. (2004). Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Cancer Epidemiol Biomarkers Prev 13:1290-1295.
23. Rinaldi S, Toniolo P, Muti P, Lundin E, Zeleniuch-Jacquotte A, Arslan A, et al. (2005). IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev 14:493-496.
24. Rohrbacher M, Risch A, Kropp S, Chang-Claude J (2005). The A(-336C) insulin-like growth factor binding protein-3 promoter polymorphism is not a modulator of breast cancer risk in Caucasian women. Cancer Epidemiol Biomarkers Prev 14:289-290.
25. Samowitz WS, Wolff RK, Ma KN, Caan B, Slattery ML (2006). Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Mutat Res 595:117-124.
26. Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN (2003). Polymorphic variation at the -202 locus in IGFBP3: influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer 107:60-64.
27. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, et al. (2001). GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control 12:673-681.
28. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S (2004). Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13:1206-1214.
29. Vorwerk P, Yamanaka Y, Spagnoli A, Oh Y, Rosenfeld RG (1998). Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J Clin Endocrinol Metab 83:1392-1395.
30. Wang L, Habuchi T, Tsuchiya N, Mitsumori K, Ohyama C, Sato K, et al. (2003). Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res 63:4407-4411.
31. Wong HL, Delellis K, Probst-Hensch N, Koh WP, Van Den Berg D, Lee HP, et al. (2005). A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol Biomarkers Pev 14:144-151.
32. Yu H, Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst J 92:1472-1489.
33. Zhang ZW, Newcomb PV, Moorghen M, Gupta J, Feakins R, Savage P, et al. (2004). Insulin-like growth factor binding protein-3: relationship to the development of gastric pre-malignancy and gastric adenocarcinoma (United Kingdom). Cancer Causes Control 15:211-218.
34. Zou T, Fleisher AS, Kong D, Yin J, Souza RF, Wang S, et al. (1998). Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues. Cancer Res 58:4802-4804.